Perrigo | PRGO - Себестоимость





Себестоимость Изменить Дата
AbbVie USD 4.55B 757M 2025-12
Abbott USD 4.92B 535M 2025-12
Bayer EUR 4.5B 194M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Coherus Biosciences USD 4.04M 324K 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Dr.Reddys Laboratories INR 36.16B 3.75B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
J&J USD 7.97B 689M 2025-12
Merck USD 3.32B 531M 2025-12
Nestle CHF 25.08B 1.48B 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Reckitt Benckiser GBP 2.75B 1.34B 2024-12
Sanofi EUR 4.29B 421M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12
Zoetis USD 743M 60M 2025-12